-
1
-
-
13344285339
-
Identification and characterization of a new member of the TNF family that induces apoptosis
-
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., and Smith, C. A. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682
-
(1995)
Immunity
, vol.3
, pp. 673-682
-
-
Wiley, S.R.1
Schooley, K.2
Smolak, P.J.3
Din, W.S.4
Huang, C.P.5
Nicholl, J.K.6
Sutherland, G.R.7
Smith, T.D.8
Rauch, C.9
Smith, C.A.10
-
2
-
-
17544367410
-
Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
-
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., and Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 12687-12690
-
-
Pitti, R.M.1
Marsters, S.A.2
Ruppert, S.3
Donahue, C.J.4
Moore, A.5
Ashkenazi, A.6
-
3
-
-
0030996297
-
The receptor for the cytotoxic ligand TRAIL
-
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., and Dixit, V. M. (1997) The receptor for the cytotoxic ligand TRAIL. Science 276, 111-113
-
(1997)
Science
, vol.276
, pp. 111-113
-
-
Pan, G.1
O'Rourke, K.2
Chinnaiyan, A.M.3
Gentz, R.4
Ebner, R.5
Ni, J.6
Dixit, V.M.7
-
4
-
-
0031253977
-
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
-
Wu, G. S., Burns, T. F., McDonald, E. R., 3rd, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and el-Deiry, W. S. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17, 141-143
-
(1997)
Nat. Genet.
, vol.17
, pp. 141-143
-
-
Wu, G.S.1
Burns, T.F.2
McDonald III, E.R.3
Jiang, W.4
Meng, R.5
Krantz, I.D.6
Kao, G.7
Gan, D.D.8
Zhou, J.Y.9
Muschel, R.10
Hamilton, S.R.11
Spinner, N.B.12
Markowitz, S.13
Wu, G.14
El-Deiry, W.S.15
-
5
-
-
0030762815
-
An antagonist decoy receptor and a death domain-containing receptor for TRAIL
-
Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R., and Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818
-
(1997)
Science
, vol.277
, pp. 815-818
-
-
Pan, G.1
Ni, J.2
Wei, Y.F.3
Yu, G.4
Gentz, R.5
Dixit, V.M.6
-
6
-
-
0030880548
-
TRAIL-R2: A novel apoptosismediating receptor for TRAIL
-
Walczak, H., Degli-Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., Goodwin, R. G., and Rauch, C. T. (1997) TRAIL-R2: a novel apoptosismediating receptor for TRAIL. EMBO J. 16, 5386-5397
-
(1997)
EMBO J
, vol.16
, pp. 5386-5397
-
-
Walczak, H.1
Degli-Esposti, M.A.2
Johnson, R.S.3
Smolak, P.J.4
Waugh, J.Y.5
Boiani, N.6
Timour, M.S.7
Gerhart, M.J.8
Schooley, K.A.9
Smith, C.A.10
Goodwin, R.G.11
Rauch, C.T.12
-
7
-
-
0031239984
-
TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
-
Screaton, G. R., Mongkolsapaya, J., Xu, X. N., Cowper, A. E., McMichael, A. J., and Bell, J. I. (1997) TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr. Biol. 7, 693-696
-
(1997)
Curr. Biol.
, vol.7
, pp. 693-696
-
-
Screaton, G.R.1
Mongkolsapaya, J.2
Xu, X.N.3
Cowper, A.E.4
McMichael, A.J.5
Bell, J.I.6
-
8
-
-
0030792712
-
Control of TRAIL induced apoptosis by a family of signaling and decoy receptors
-
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P., and Ashkenazi, A. (1997) Control of TRAIL induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821
-
(1997)
Science
, vol.277
, pp. 818-821
-
-
Sheridan, J.P.1
Marsters, S.A.2
Pitti, R.M.3
Gurney, A.4
Skubatch, M.5
Baldwin, D.6
Ramakrishnan, L.7
Gray, C.L.8
Baker, K.9
Wood, W.I.10
Goddard, A.D.11
Godowski, P.12
Ashkenazi, A.13
-
9
-
-
0032489353
-
TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
-
Pan, G., Ni, J., Yu, G., Wei, Y. F., and Dixit, V. M. (1998) TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett. 424, 41-45
-
(1998)
FEBS Lett
, vol.424
, pp. 41-45
-
-
Pan, G.1
Ni, J.2
Yu, G.3
Wei, Y.F.4
Dixit, V.M.5
-
10
-
-
25144489068
-
Overview of cell death signaling pathways
-
Jin, Z., and El-Deiry, W. S. (2005) Overview of cell death signaling pathways. Cancer Biol. Ther. 4, 139-163
-
(2005)
Cancer Biol. Ther.
, vol.4
, pp. 139-163
-
-
Jin, Z.1
El-Deiry, W.S.2
-
11
-
-
0032575714
-
Death receptors: Signaling and modulation
-
Ashkenazi, A., and Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308
-
(1998)
Science
, vol.281
, pp. 1305-1308
-
-
Ashkenazi, A.1
Dixit, V.M.2
-
12
-
-
33644832724
-
Targeted induction of apoptosis in cancer management: The emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents
-
Rowinsky, E. K. (2005) Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J. Clin. Oncol. 23, 9394-9407
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 9394-9407
-
-
Rowinsky, E.K.1
-
13
-
-
70349318434
-
Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: Results of a phase i and pharmacokinetic study
-
Leong, S., Cohen, R. B., Gustafson, D. L., Langer, C. J., Camidge, D. R., Padavic, K., Gore, L., Smith, M., Chow, L. Q., von Mehren, M., O'Bryant, C., Hariharan, S., Diab, S., Fox, N. L., Miceli, R., and Eckhardt, S. G. (2009) Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study. J. Clin. Oncol. 27, 4413-4421
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 4413-4421
-
-
Leong, S.1
Cohen, R.B.2
Gustafson, D.L.3
Langer, C.J.4
Camidge, D.R.5
Padavic, K.6
Gore, L.7
Smith, M.8
Chow, L.Q.9
Von Mehren, M.10
O'Bryant, C.11
Hariharan, S.12
Diab, S.13
Fox, N.L.14
Miceli, R.15
Eckhardt, S.G.16
-
14
-
-
69949110775
-
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: A phase i study
-
Mom, C. H., Verweij, J., Oldenhuis, C. N., Gietema, J. A., Fox, N. L., Miceli, R., Eskens, F. A., Loos, W. J., de Vries, E. G., and Sleijfer, S. (2009) Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study. Clin. Cancer Res. 15, 5584-5590
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 5584-5590
-
-
Mom, C.H.1
Verweij, J.2
Oldenhuis, C.N.3
Gietema, J.A.4
Fox, N.L.5
Miceli, R.6
Eskens, F.A.7
Loos, W.J.8
De Vries, E.G.9
Sleijfer, S.10
-
15
-
-
3543035176
-
Rare loss-of-function mutation of a death receptor gene in head and neck cancer
-
Pai, S. I., Wu, G. S., Ozören, N., Wu, L., Jen, J., Sidransky, D., and El-Deiry, W. S. (1998) Rare loss-of-function mutation of a death receptor gene in head and neck cancer. Cancer Res. 58, 3513-3518
-
(1998)
Cancer Res
, vol.58
, pp. 3513-3518
-
-
Pai, S.I.1
Wu, G.S.2
Ozören, N.3
Wu, L.4
Jen, J.5
Sidransky, D.6
El-Deiry, W.S.7
-
16
-
-
0037621450
-
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation
-
Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C., Zangemeister-Wittke, U., and Stahel, R. (2003) Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ. 10, 356-364
-
(2003)
Cell Death Differ
, vol.10
, pp. 356-364
-
-
Hopkins-Donaldson, S.1
Ziegler, A.2
Kurtz, S.3
Bigosch, C.4
Kandioler, D.5
Ludwig, C.6
Zangemeister-Wittke, U.7
Stahel, R.8
-
17
-
-
34948894931
-
Deathreceptor O-glycosylation controls tumor cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
-
Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., Huw, L., Katta, V., Cavet, G., Hymowitz, S. G., Amler, L., and Ashkenazi, A. (2007) Deathreceptor O-glycosylation controls tumor cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 13, 1070-1077
-
(2007)
Nat. Med.
, vol.13
, pp. 1070-1077
-
-
Wagner, K.W.1
Punnoose, E.A.2
Januario, T.3
Lawrence, D.A.4
Pitti, R.M.5
Lancaster, K.6
Lee, D.7
Von Goetz, M.8
Yee, S.F.9
Totpal, K.10
Huw, L.11
Katta, V.12
Cavet, G.13
Hymowitz, S.G.14
Amler, L.15
Ashkenazi, A.16
-
18
-
-
0035851189
-
Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach
-
Burns, T. F., and El-Deiry, W. S. (2001) Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J. Biol. Chem. 276, 37879-37886
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 37879-37886
-
-
Burns, T.F.1
El-Deiry, W.S.2
-
19
-
-
0037151079
-
An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis
-
Kim, Y., Suh, N., Sporn, M., and Reed, J. C. (2002) An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 277, 22320-22329
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 22320-22329
-
-
Kim, Y.1
Suh, N.2
Sporn, M.3
Reed, J.C.4
-
20
-
-
0037312929
-
Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP
-
Hietakangas, V., Poukkula, M., Heiskanen, K. M., Karvinen, J. T., Sistonen, L., and Eriksson, J. E. (2003) Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol. Cell. Biol. 23, 1278-1291
-
(2003)
Mol. Cell. Biol.
, vol.23
, pp. 1278-1291
-
-
Hietakangas, V.1
Poukkula, M.2
Heiskanen, K.M.3
Karvinen, J.T.4
Sistonen, L.5
Eriksson, J.E.6
-
21
-
-
33646542701
-
Src kinase phosphorylates Caspase-8 on Tyr380: A novel mechanism of apoptosis suppression
-
Cursi, S., Rufini, A., Stagni, V., Condò, I., Matafora, V., Bachi, A., Bonifazi, A. P., Coppola, L., Superti-Furga, G., Testi, R., and Barilà, D. (2006) Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J. 25, 1895-1905
-
(2006)
EMBO J
, vol.25
, pp. 1895-1905
-
-
Cursi, S.1
Rufini, A.2
Stagni, V.3
Condò, I.4
Matafora, V.5
Bachi, A.6
Bonifazi, A.P.7
Coppola, L.8
Superti-Furga, G.9
Testi, R.10
Barilà, D.11
-
22
-
-
70149122276
-
TRAIL as a target in anti-cancer therapy
-
Wu, G. S. (2009) TRAIL as a target in anti-cancer therapy. Cancer Lett. 285, 1-5
-
(2009)
Cancer Lett
, vol.285
, pp. 1-5
-
-
Wu, G.S.1
-
23
-
-
77956321948
-
Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells
-
Xu, J., Zhou, J. Y., Wei, W. Z., and Wu, G. S. (2010) Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells. PLoS One 5, e10226
-
(2010)
PLoS One
, vol.5
-
-
Xu, J.1
Zhou, J.Y.2
Wei, W.Z.3
Wu, G.S.4
-
24
-
-
84872190750
-
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells
-
Azijli, K., Yuvaraj, S., Peppelenbosch, M. P., Würdinger, T., Dekker, H., Joore, J., van Dijk, E., Quax, W. J., Peters, G. J., de Jong, S., and Kruyt, F. A. (2012) Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells. J. Cell Sci. 125, 4651-4661
-
(2012)
J. Cell Sci.
, vol.125
, pp. 4651-4661
-
-
Azijli, K.1
Yuvaraj, S.2
Peppelenbosch, M.P.3
Würdinger, T.4
Dekker, H.5
Joore, J.6
Van Dijk, E.7
Quax, W.J.8
Peters, G.J.9
De Jong, S.10
Kruyt, F.A.11
-
25
-
-
4544235743
-
C-Src and cooperating partners in human cancer
-
Ishizawar, R., and Parsons, S. J. (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6, 209-214
-
(2004)
Cancer Cell
, vol.6
, pp. 209-214
-
-
Ishizawar, R.1
Parsons, S.J.2
-
26
-
-
67649311599
-
Latent bone metastasis in breast cancer tied to Src-dependent survival signals
-
Zhang, X. H., Wang, Q., Gerald, W., Hudis, C. A., Norton, L., Smid, M., Foekens, J. A., and Massagué, J. (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67-78
-
(2009)
Cancer Cell
, vol.16
, pp. 67-78
-
-
Zhang, X.H.1
Wang, Q.2
Gerald, W.3
Hudis, C.A.4
Norton, L.5
Smid, M.6
Foekens, J.A.7
Massagué, J.8
-
27
-
-
54249144029
-
Src and ADAM-17-mediated shedding of transforming growth factor-α is a mechanism of acute resistance to TRAIL
-
Van Schaeybroeck, S., Kelly, D. M., Kyula, J., Stokesberry, S., Fennell, D. A., Johnston, P. G., and Longley, D. B. (2008) Src and ADAM-17-mediated shedding of transforming growth factor-α is a mechanism of acute resistance to TRAIL. Cancer Res. 68, 8312-8321
-
(2008)
Cancer Res.
, vol.68
, pp. 8312-8321
-
-
Van Schaeybroeck, S.1
Kelly, D.M.2
Kyula, J.3
Stokesberry, S.4
Fennell, D.A.5
Johnston, P.G.6
Longley, D.B.7
-
28
-
-
37749015044
-
A RNA interference screen identifies the protein phosphatase 2A subunit PR55 γ as a stress-sensitive inhibitor of c-SRC
-
Eichhorn, P. J., Creyghton, M. P., Wilhelmsen, K., van Dam, H., and Bernards, R. (2007) A RNA interference screen identifies the protein phosphatase 2A subunit PR55 γ as a stress-sensitive inhibitor of c-SRC. PLoS Genet. 3, e218
-
(2007)
PLoS Genet.
, vol.3
-
-
Eichhorn, P.J.1
Creyghton, M.P.2
Wilhelmsen, K.3
Van Dam, H.4
Bernards, R.5
-
29
-
-
58049186804
-
Protein phosphatase 2A regulatory subunits and cancer
-
Eichhorn, P. J., Creyghton, M. P., and Bernards, R. (2009) Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 1795, 1-15
-
(2009)
Biochim. Biophys. Acta
, vol.1795
, pp. 1-15
-
-
Eichhorn, P.J.1
Creyghton, M.P.2
Bernards, R.3
-
30
-
-
70350340056
-
Serine/threonine phosphatases: Mechanism through structure
-
Shi, Y. (2009) Serine/threonine phosphatases: mechanism through structure. Cell 139, 468-484
-
(2009)
Cell
, vol.139
, pp. 468-484
-
-
Shi, Y.1
-
31
-
-
0035252894
-
Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
-
Janssens, V., and Goris, J. (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353, 417-439
-
(2001)
Biochem. J.
, vol.353
, pp. 417-439
-
-
Janssens, V.1
Goris, J.2
-
32
-
-
77955595320
-
The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma
-
Lu, J., Zhuang, Z., Song, D. K., Mehta, G. U., Ikejiri, B., Mushlin, H., Park, D. M., and Lonser, R. R. (2010) The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma. J. Neurosurg. 113, 225-233
-
(2010)
J. Neurosurg.
, vol.113
, pp. 225-233
-
-
Lu, J.1
Zhuang, Z.2
Song, D.K.3
Mehta, G.U.4
Ikejiri, B.5
Mushlin, H.6
Park, D.M.7
Lonser, R.R.8
-
33
-
-
0029928561
-
Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bcl-2
-
Wu, G. S., and El-Deiry, W. S. (1996) Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bcl-2. Clin. Cancer Res. 2, 623-633
-
(1996)
Clin. Cancer Res.
, vol.2
, pp. 623-633
-
-
Wu, G.S.1
El-Deiry, W.S.2
-
34
-
-
1142287412
-
Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death
-
Muppidi, J. R., and Siegel, R. M. (2004) Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5, 182-189
-
(2004)
Nat. Immunol.
, vol.5
, pp. 182-189
-
-
Muppidi, J.R.1
Siegel, R.M.2
-
35
-
-
33749164762
-
Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2
-
Mérino, D., Lalaoui, N., Morizot, A., Schneider, P., Solary, E., and Micheau, O. (2006) Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol. Cell. Biol. 26, 7046-7055
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 7046-7055
-
-
Mérino, D.1
Lalaoui, N.2
Morizot, A.3
Schneider, P.4
Solary, E.5
Micheau, O.6
-
36
-
-
34547123570
-
Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells
-
Song, J. H., Tse, M. C., Bellail, A., Phuphanich, S., Khuri, F., Kneteman, N. M., and Hao, C. (2007) Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Res. 67, 6946-6955
-
(2007)
Cancer Res.
, vol.67
, pp. 6946-6955
-
-
Song, J.H.1
Tse, M.C.2
Bellail, A.3
Phuphanich, S.4
Khuri, F.5
Kneteman, N.M.6
Hao, C.7
-
37
-
-
48749118203
-
Targeting Src in breast cancer
-
Finn, R. S. (2008) Targeting Src in breast cancer. Ann. Oncol. 19, 1379-1386
-
(2008)
Ann. Oncol.
, vol.19
, pp. 1379-1386
-
-
Finn, R.S.1
-
38
-
-
77956514336
-
Cross-talk between serine/threonine protein phosphatase 2A and protein tyrosine phosphatase 1B regulates Src activation and adhesion of integrin alphaIIbbeta3 to fibrinogen
-
Pradhan, S., Alrehani, N., Patel, V., Khatlani, T., and Vijayan, K. V. (2010) Cross-talk between serine/threonine protein phosphatase 2A and protein tyrosine phosphatase 1B regulates Src activation and adhesion of integrin alphaIIbbeta3 to fibrinogen. J. Biol. Chem. 285, 29059-29068
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 29059-29068
-
-
Pradhan, S.1
Alrehani, N.2
Patel, V.3
Khatlani, T.4
Vijayan, K.V.5
-
39
-
-
71349087492
-
C-Cbl acts as a mediator of Src-induced activation of the PI3KAkt signal transduction pathway during TRAIL treatment
-
Song, J. J., Kim, J. H., Sun, B. K., Alcala, M. A., Jr., Bartlett, D. L., and Lee, Y. J. (2010) c-Cbl acts as a mediator of Src-induced activation of the PI3KAkt signal transduction pathway during TRAIL treatment. Cell Signal. 22, 377-385
-
(2010)
Cell Signal
, vol.22
, pp. 377-385
-
-
Song, J.J.1
Kim, J.H.2
Sun, B.K.3
Alcala Jr., M.A.4
Bartlett, D.L.5
Lee, Y.J.6
|